10 Surprising Stocks That Skyrocketed Today

Page 9 of 9

1. ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)

Acadia Pharmaceuticals soared by 26.48 percent on Friday to finish at $22.26 apiece after securing the backing of a US District Court concerning a patent infringement case versus Aurobindo Pharma (NSE:ARBN).

The case stemmed from a case filed by ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) against Aurobindo for allegedly infringing claims 4 and 5 of US Patent No. 11,452,721. It is alleged that the latter committed patent infringement of its drug Nuplazid.

Additionally, the judge said that Aurobindo failed to prove that ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) claims were invalid.

The ruling marked a significant milestone for ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) to protect its intellectual property rights.

While we acknowledge the potential of ACAD as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. There is an AI stock that went up since the beginning of 2025, while popular AI stocks lost around 25%. If you are looking for an AI stock that is more promising than ACAD but that trades at less than 5 times its earnings, check out our report about this cheapest AI stock.

READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires.

Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.

Page 9 of 9